Abingdon Health (LSE:ABDX) ROE % Adjusted to Book Value : -13.63% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health ROE % Adjusted to Book Value?

Abingdon Health's ROE % for the quarter that ended in Dec. 2023 was -99.94%. Abingdon Health's PB Ratio for the quarter that ended in Dec. 2023 was 7.33. Abingdon Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -13.63%.

Abingdon Health ROE % Adjusted to Book Value Historical Data

The historical data trend for Abingdon Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health ROE % Adjusted to Book Value Chart

Abingdon Health Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-26.33

-73.65

-15.23

Abingdon Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial					-28.89	-105.66	-47.04	-12.21	-13.63

Competitive Comparison of Abingdon Health's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Abingdon Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abingdon Health's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Abingdon Health's ROE % Adjusted to Book Value falls into.

Abingdon Health ROE % Adjusted to Book Value Calculation

Abingdon Health's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-73.11%	/	4.80
	=	-15.23%

Abingdon Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-99.94%	/	7.33
	=	-13.63%

Abingdon Health ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Abingdon Health's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (LSE:ABDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines